Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Thomas E SiffDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.ORCID 0000-0001-6000-6285
Paige E AllenDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.ORCID 0000-0002-0299-7380
David L ArmisteadDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.
Jason R HuntDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.
Steven J RollandDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0001-9622-9157
Hervé AgaisseDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0002-3350-0218
Jason A CarlyonDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.ORCID 0000-0003-2778-5066
Funding
Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesisR01AI167857 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jason A Carlyon · 2022 to 2026
$2.9M
Host factors in shigellosisR01AI179778 · NIAID · UNIVERSITY OF VIRGINIA · PI HERVE F AGAISSE · 2024 to 2026
$2.2M
VCU NIGMS Mentoring supplementT32GM144294 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI David Delmar Limbrick · 2022 to 2026
$1.3M
Multifunctional roles of an Orientia tsutsugamushi nucleomodulinF32AI174656 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Paige Allen · 2023 to 2026
$224k
National Institute of Allergy and Infectious Diseases F32 AI174656A1NIAID NIH HHS F32 AI174656NIAID NIH HHS R01 AI167857NIAID NIH HHS R01 AI179778NIGMS NIH HHS T32 GM144294
6 · The paper itself
Abstract
Scrub typhus is an emerging chigger-borne disease caused by the obligate intracellular bacterium
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.